These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23994885)

  • 1. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
    Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
    J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.
    Altomare E; Fallarini S; Biaggi G; Gattoni E; Botta M; Lombardi G
    Cancer Biol Ther; 2012 Jul; 13(9):702-11. PubMed ID: 22684580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.
    Wu L; Yun Z; Tagawa T; De la Maza L; Wu MO; Yu J; Zhao Y; de Perrot M
    Cancer Immunol Immunother; 2014 Dec; 63(12):1285-96. PubMed ID: 25183171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.
    Anraku M; Tagawa T; Wu L; Yun Z; Keshavjee S; Zhang L; Johnston MR; de Perrot M
    J Immunol; 2010 Jul; 185(2):956-66. PubMed ID: 20548032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
    Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
    J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
    Guan P; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphoma.
    Bjordahl RL; Gapin L; Marrack P; Refaeli Y
    PLoS One; 2012; 7(8):e42635. PubMed ID: 22880059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
    Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
    Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer T cell activation increases iNOS
    Paul S; Chhatar S; Mishra A; Lal G
    J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.
    Nur H; Fostier K; Aspeslagh S; Renmans W; Bertrand E; Leleu X; Favreau M; Breckpot K; Schots R; De Waele M; Van Valckenborgh E; De Bruyne E; Facon T; Elewaut D; Vanderkerken K; Menu E
    PLoS One; 2013; 8(5):e65075. PubMed ID: 23741460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
    Yang G; Artiaga BL; Lewis ST; Driver JP
    Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
    Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
    J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.